1. Market & Company News

  2. EQS-News: Poolbeg Pharma identifies new RSV drug candidates

Source - DGAP Regulatory

EQS-News: Poolbeg Pharma PLC
Poolbeg Pharma identifies new RSV drug candidates

22.12.2022 / 11:47 CET/CEST
The issuer is solely responsible for the content of this announcement.

0.jpgContact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com


News Source: News Direct

22.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Poolbeg Pharma PLC
United States
ISIN: GB00BKPG7Z60
EQS News ID: 1520089

 
End of News EQS News Service

1520089  22.12.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1520089&application_name=news&site_id=morningstar
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Poolbeg Pharma PLC (POLB)

+0.20p (+1.72%)
delayed 15:49PM
< Back

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of directors' buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
25 Apr 2024 Subscribe now

Market Overview

UK 350 Risers and Fallers